Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05223_nanopub.RA1Br6ql6Io9SvjUsQWYrouXoVHgaw26qdYl1Q9bFCQWE#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05223 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05223 label "SB939 [drugbank:DB05223]" assertion.
- drugbank:DB05223 seeAlso DB05223 assertion.
- drugbank:DB05223 identifier "drugbank:DB05223" assertion.
- drugbank:DB05223 description "SB939 is a novel HDAC inhibitor with improved in vivo properties compared to other HDAC inhibitors currently in clinical trials, allowing oral dosing. Data demonstrate that SB939 is a potent and effective anti-tumor drug with potential as an oral therapy for a variety of human hematological and solid tumors." assertion.
- drugbank:DB05223 title "SB939" assertion.
- drugbank:DB05223 bio2rdf_vocabulary:identifier "DB05223" assertion.
- drugbank:DB05223 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05223 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05223" assertion.
- drugbank:DB05223 bio2rdf_vocabulary:x-identifiers.org DB05223 assertion.
- drugbank:DB05223 drugbank_vocabulary:drugbank-id "DB05223" assertion.
- drugbank:DB05223 drugbank_vocabulary:x-cas cas: assertion.